Gauri Bapayeva

Dr. Gauri Bapayeva


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
GBGauri Bapayeva
Gauri Bapayeva
Gulzhanat AimagambetovaGulzhanat Aimagambetova
Gulzhanat Aimagambetova
AIAlpamys Issanov
Alpamys Issanov
MTMilan Terzić
Milan Terzić
TUTalshyn Muchadesovna Ukybassova
Talshyn Muchadesovna Ukybassova
Milan TerzicMilan Terzic
Milan Terzic
Although it is clear that infertility leads to heightened stress for patients, the impact of depressed mood and anxiety on treatment outcome is inconsistently reported. The aim of this study was to evaluate the effect of stress, depression and anxiety on in vitro fertilization (IVF) outcomes in Kazakhstani public assisted reproductive technology (ART) clinics. The prospective cohort study was performed between June 2019 and September 2020 using questionnaires to assess psychological stress, depressed mood and anxiety in women referred to IVF clinics in two public clinical centers in Kazakhstan, Nur-Sultan and Aktobe. Our study sample comprised 142 women with the average age of 33.9 ± 4.9 years, and infertility duration 6.0 ± 3.5 years. More than half of respondents had Center for Epidemiological Studies Depression Scale (CES-D) scores higher than 16, indicating their risk of developing clinical depression. Ninety-one percent of women from Aktobe city were at risk for clinical depression (p < 0.001). Aktobe city respondents had higher stress subscale scores and anxiety scale scores (p < 0.001) than Nur-Sultan respondents. Statistical analysis showed that IVF outcome was not significantly associated with depression and stress, while the higher anxiety scale scores were negatively associated with clinical pregnancy after IVF.

AAAyazhan Akhatova
Ayazhan Akhatova
Gulzhanat AimagambetovaGulzhanat Aimagambetova
Gulzhanat Aimagambetova
GBGauri Bapayeva
Gauri Bapayeva
Antonio Simone LaganàAntonio Simone Laganà
Antonio Simone Laganà
VCVito Chiantera
Vito Chiantera
Milan TerzicMilan Terzic
Milan Terzic
Novel treatment options for uterine fibroids, such as uterine artery embolization (UAE), ultrasound-guided and magnetic resonance-guided high-intensity focused ultrasound (USgHIFU and MRgHIFU), and transcervical radiofrequency ablation (TFA) methods, are widely used in clinical practice. This systematic review and meta-analysis (CRD42022297312) aims to assess and compare reproductive and obstetric outcomes in women who underwent these minimally invasive approaches for uterine fibroids. The search was performed in PubMed, Google Scholar, ScienceDirect, Cochrane Library, Scopus, Web of Science and Embase. Risk of bias was assessed using the Newcastle–Ottawa Scale (NOS) and Cochrane guidelines. The articles were selected to meet the following eligibility criteria: (1) research article, (2) human subject research, and (3) the study of pregnancy outcomes after the treatment of uterine fibroids by either one of three methods—UAE, HIFU, and TFA. The analysis of 25 eligible original articles shows a similar rate of live births for UAE, USgHIFU, MRgHIFU, and TFA (70.8%, 73.5%, 70%, and 75%, respectively). The number of pregnancies varied considerably among these studies, as well as the mean age of pregnant women. However, the results of pregnancy outcomes for TFA are insufficient to draw firm conclusions, since only 24 women became pregnant in these studies, resulting in three live births. The miscarriage rate was highest in the UAE group (19.2%). USgHIFU was associated with a higher rate of placental abnormalities compared to UAE (2.8% vs. 1.6%). The pooled estimate of pregnancies was 17.31% to 44.52% after UAE, 18.69% to 78.53% after HIFU, and 2.09% to 7.63% after TFA. The available evidence confirmed that these minimally invasive uterine-sparing treatment options for uterine fibroids are a good approach for patients wishing to preserve their fertility, with comparable reproductive and obstetric outcomes among the different techniques.

1 October 2016 in Reproductive Toxicology
Verified
Journal Article
Closed access
GBGauri Bapayeva
Gauri Bapayeva
RIRaushan Issayeva
Raushan Issayeva
AZAkmaral Zhumadilova
Akmaral Zhumadilova
RNRaushan Nurkasimova
Raushan Nurkasimova
SKSaltanat Kulbayeva
Saltanat Kulbayeva
RTRenata Tleuzhan
Renata Tleuzhan

9 June 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
Milan TerzicMilan Terzic
Milan Terzic
Gulzhanat AimagambetovaGulzhanat Aimagambetova
Gulzhanat Aimagambetova
MTMilan Terzić
Milan Terzić
Milena RadunovićMilena Radunović
Milena Radunović
GBGauri Bapayeva
Gauri Bapayeva
Antonio Simone LaganàAntonio Simone Laganà
Antonio Simone Laganà
Preterm labor is defined as a birth before 37 weeks of gestation and occurs in 5–20% of pregnancies. Preterm labor, as multifactorial entity associated with a high risk of neonatal morbidity and mortality, is influenced by maternal, fetal and environmental factors. Microbiological studies suggest that infectious pathogens may account for 25–40% of preterm birth. Infections of different sites, like genital, urinary tract infections, and pneumonia, are linked to the preterm labor. The most recent epidemiological studies consistently report that maternal periodontal disease is associated with preterm delivery, as well as the association between the presence of pathogenic oral bacteria in the placenta and adverse pregnancy outcomes. On the other hand, some previously published papers found periodontal bacteria in placentas of term pregnancies. In spite of a huge research done on the topic, both experimental and clinical, there are many controversial opinions about the role of periodontal infections in preterm birth. Thus, this comprehensive review addresses this very important topic and evaluates novel strategies of preventive and therapeutic approaches.

1 April 2020 in Minerva Medica
Verified
Journal Article
Closed access
Milan TerzicMilan Terzic
Milan Terzic
Gulzhanat AimagambetovaGulzhanat Aimagambetova
Gulzhanat Aimagambetova
Simone GarzonSimone Garzon
Simone Garzon
GBGauri Bapayeva
Gauri Bapayeva
TUTalshyn Ukybassova
Talshyn Ukybassova
Antonio Simone LaganàAntonio Simone Laganà
Antonio Simone Laganà
Endometriosis is a chronic benign gynecological disease with symptoms that can severely impact quality of life and well-being. Women affected by endometriotic ovarian cyst could have associated infertility problems. Infertility affects 30% to 50% of women with endometriosis. Women with endometriosis are at risk of decreased ovarian reserve, due to the disease pathophysiologic mechanisms. Generally, infertility management include surgical procedure (usually with minimally invasive approach) and ovulation induction with intrauterine insemination or in vitro fertilization. Fertility preservation technologies also include oocyte or embryo freezing and ovarian tissue cryopreservation. Approach to patients with endometriotic cysts still remains controversial, and a multidisciplinary approach is a key factor to achieve the best outcome with appropriate patient counselling. Such management by a multidisciplinary team is a key factor in achieving the successful outcome.

24 February 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DADiana Alizhan
Diana Alizhan
TUTalshyn Muchadesovna Ukybassova
Talshyn Muchadesovna Ukybassova
GBGauri Bapayeva
Gauri Bapayeva
Gulzhanat AimagambetovaGulzhanat Aimagambetova
Gulzhanat Aimagambetova
KKKuralay Kongrtay
Kuralay Kongrtay
Milan TerzicMilan Terzic
Milan Terzic
Background/Objectives: Persistent high-risk human papillomavirus (HPV) infections are the leading cause of cervical cancer. Developing evidence suggests that the cervicovaginal microbiome plays a significant role in modulating HPV persistence and progression to cervical neoplasia. This review synthesizes the current knowledge on the interplay between the cervicovaginal microbiome and local immunity in HPV infections, emphasizing microbial diversity, immune responses, and potential therapeutic implications. Methods: A thorough review of the literature was performed using Embase, PubMed, Scopus, and Google Scholar, encompassing studies published between 2000 and 2024. Studies examining the composition of the microbiome, immune responses, and HPV-related outcomes were evaluated and synthesized into a comprehensive review. Results: A Lactobacillus-dominant microbiome, particularly with L. crispatus, creates a protective environment through lactic acid production, maintenance of low pH, and anti-inflammatory immune modulation, facilitating HPV clearance. Dysbiosis, often characterized by a dominance of L. iners and overgrowth of anaerobic bacteria, fosters chronic inflammation, cytokine imbalance, and a microenvironment conducive to HPV persistence and progression. Hormonal changes and menopause exacerbate these microbial shifts, increasing the risk of cervical lesions. Studies suggest that cytokine profiles and antimicrobial peptides significantly influence local immune responses, further modulating infection outcomes. Conclusions: The cervicovaginal microbiome is a critical determinant in HPV infection outcomes, with therapeutic potential for modulating the microbiome to enhance immune responses and prevent cervical cancer. Personalized microbiome-targeted therapies may offer a novel avenue for managing HPV and reducing cervical cancer incidence.